| Year |
Citation |
Score |
| 2024 |
Taylor MK, Burns JM, Choi IY, Herda TJ, Lee P, Smith AN, Sullivan DK, Swerdlow RH, Wilkins HM. Protocol for a single-arm, pilot trial of creatine monohydrate supplementation in patients with Alzheimer's disease. Pilot and Feasibility Studies. 10: 42. PMID 38414003 DOI: 10.1186/s40814-024-01469-5 |
0.673 |
|
| 2024 |
Harris JL, Wang X, Christian SK, Novikova L, Kalani A, Hui D, Ferren S, Barbay S, Ortiz JP, Nudo RJ, Brooks WM, Wilkins HM, Chalise P, Michaelis ML, Michaelis EK, ... Swerdlow RH, et al. Traumatic Brain Injury Alters the Trajectory of Age-Related Mitochondrial Change. Journal of Alzheimer's Disease : Jad. PMID 38306050 DOI: 10.3233/JAD-231237 |
0.629 |
|
| 2023 |
Alghusen IM, Carman MS, Wilkins H, Ephrame SJ, Qiang A, Dias WB, Fedosyuk H, Denson AR, Swerdlow RH, Slawson C. O-GlcNAc regulates the mitochondrial integrated stress response by regulating ATF4. Frontiers in Aging Neuroscience. 15: 1326127. PMID 38192280 DOI: 10.3389/fnagi.2023.1326127 |
0.666 |
|
| 2023 |
Samanta S, Akhter F, Roy A, Chen D, Turner B, Wang Y, Clemente N, Wang C, Swerdlow RH, Battaile KP, Lovell S, Yan SF, Yan SS. New cyclophilin D inhibitor rescues mitochondrial and cognitive function in Alzheimer's disease. Brain : a Journal of Neurology. PMID 38146639 DOI: 10.1093/brain/awad432 |
0.416 |
|
| 2023 |
Pal R, Hui D, Menchen H, Zhao H, Mozziconacci O, Wilkins H, Blagg BSJ, Schöneich C, Swerdlow RH, Michaelis ML, Michaelis EK. Protection against Aβ-induced neuronal damage by KU-32: PDHK1 inhibition as important target. Frontiers in Aging Neuroscience. 15: 1282855. PMID 38035268 DOI: 10.3389/fnagi.2023.1282855 |
0.647 |
|
| 2023 |
Jia K, Tian J, Wang T, Guo L, Xuan Z, Swerdlow RH, Du H. Mitochondria-sequestered Aβ renders synaptic mitochondria vulnerable in the elderly with a risk of Alzheimer disease. Jci Insight. 8. PMID 37991017 DOI: 10.1172/jci.insight.174290 |
0.386 |
|
| 2023 |
Shvetcov A, Thomson S, Spathos J, Cho AN, Wilkins HM, Andrews SJ, Delerue F, Couttas TA, Issar JK, Isik F, Kaur S, Drummond E, Dobson-Stone C, Duffy SL, Rogers NM, ... ... Swerdlow RH, et al. Blood-Based Transcriptomic Biomarkers Are Predictive of Neurodegeneration Rather Than Alzheimer's Disease. International Journal of Molecular Sciences. 24. PMID 37834458 DOI: 10.3390/ijms241915011 |
0.618 |
|
| 2023 |
Flannagan K, Stopperan JA, Hauger BM, Troutwine BR, Lysaker CR, Strope TA, Csikos Drummond V, Gilmore CA, Swerdlow NA, Draper JM, Gouvion CM, Vivian JL, Haeri M, Swerdlow RH, Wilkins HM. Cell type and sex specific mitochondrial phenotypes in iPSC derived models of Alzheimer's disease. Frontiers in Molecular Neuroscience. 16: 1201015. PMID 37614699 DOI: 10.3389/fnmol.2023.1201015 |
0.689 |
|
| 2023 |
Finney CA, Wilkins HM, Swerdlow RH, Brown DA. Activators of neurotoxic microglia in neurodegeneration: is the answer in blood? Immunology and Cell Biology. PMID 37524376 DOI: 10.1111/imcb.12674 |
0.544 |
|
| 2023 |
Zhang C, Chen H, Rodriguez Y, Ma X, Swerdlow RH, Zhang J, Ding WX. A Perspective on Autophagy and Transcription Factor EB in Alcohol-Associated Alzheimer's Disease. Biochemical Pharmacology. 115576. PMID 37127251 DOI: 10.1016/j.bcp.2023.115576 |
0.327 |
|
| 2023 |
Du F, Yu Q, Swerdlow RH, Waites CL. Glucocorticoid-driven mitochondrial damage stimulates Tau pathology. Brain : a Journal of Neurology. PMID 37070763 DOI: 10.1093/brain/awad127 |
0.41 |
|
| 2023 |
Swerdlow RH. The Alzheimer's Disease Mitochondrial Cascade Hypothesis: A Current Overview. Journal of Alzheimer's Disease : Jad. PMID 36806512 DOI: 10.3233/JAD-221286 |
0.434 |
|
| 2023 |
Gabrielli AP, Weidling I, Ranjan A, Wang X, Novikova L, Chowdhury SR, Menta B, Berkowicz A, Wilkins HM, Peterson KR, Swerdlow RH. Mitochondria Profoundly Influence Apolipoprotein E Biology. Journal of Alzheimer's Disease : Jad. PMID 36776072 DOI: 10.3233/JAD-221177 |
0.817 |
|
| 2023 |
Zhang X, Wu L, Swerdlow RH, Zhao L. Opposing Effects of ApoE2 and ApoE4 on Glycolytic Metabolism in Neuronal Aging Supports a Warburg Neuroprotective Cascade against Alzheimer's Disease. Cells. 12. PMID 36766752 DOI: 10.3390/cells12030410 |
0.306 |
|
| 2022 |
Koppel SJ, Wilkins HM, Weidling IW, Wang X, Menta BW, Swerdlow RH. β-Hydroxybutyrate preferentially enhances neuron over astrocyte respiration while signaling cellular quiescence. Mitochondrion. 68: 125-137. PMID 36516926 DOI: 10.1016/j.mito.2022.12.004 |
0.789 |
|
| 2022 |
Harerimana NV, Paliwali D, Romero-Molina C, Bennett DA, Pa J, Goate A, Swerdlow RH, Andrews SJ. The role of mitochondrial genome abundance in Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 36224040 DOI: 10.1002/alz.12812 |
0.403 |
|
| 2022 |
Watts A, Chalise P, Hu J, Hui D, Pa J, Andrews SJ, Michaelis EK, Swerdlow RH. A Mitochondrial DNA Haplogroup Defines Patterns of Five-Year Cognitive Change. Journal of Alzheimer's Disease : Jad. PMID 35964186 DOI: 10.3233/JAD-220298 |
0.315 |
|
| 2022 |
Taylor MK, Sullivan DK, Keller JE, Burns JM, Swerdlow RH. Potential for Ketotherapies as Amyloid-Regulating Treatment in Individuals at Risk for Alzheimer's Disease. Frontiers in Neuroscience. 16: 899612. PMID 35784855 DOI: 10.3389/fnins.2022.899612 |
0.351 |
|
| 2022 |
Troutwine BR, Strope TA, Franczak E, Lysaker CR, Hamid L, Mansel C, Stopperan JA, Gouvion CM, Haeri M, Swerdlow RH, Wilkins HM. Mitochondrial function and Aβ in Alzheimer's disease postmortem brain. Neurobiology of Disease. 105781. PMID 35667615 DOI: 10.1016/j.nbd.2022.105781 |
0.711 |
|
| 2022 |
Ashleigh T, Swerdlow RH, Beal MF. The role of mitochondrial dysfunction in Alzheimer's disease pathogenesis. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 35522844 DOI: 10.1002/alz.12683 |
0.425 |
|
| 2022 |
Wang X, Berkowicz A, King K, Menta B, Gabrielli AP, Novikova L, Troutwine B, Pleen J, Wilkins HM, Swerdlow RH. Pharmacologic enrichment of exosome yields and mitochondrial cargo. Mitochondrion. 64: 136-144. PMID 35398304 DOI: 10.1016/j.mito.2022.04.001 |
0.82 |
|
| 2022 |
Sandberg AA, Manning E, Wilkins HM, Mazzarino R, Minckley T, Swerdlow RH, Patterson D, Qin Y, Linseman DA. Mitochondrial Targeting of Amyloid-β Protein Precursor Intracellular Domain Induces Hippocampal Cell Death via a Mechanism Distinct from Amyloid-β. Journal of Alzheimer's Disease : Jad. PMID 35253745 DOI: 10.3233/JAD-215108 |
0.756 |
|
| 2021 |
Wilkins HM, Troutwine BR, Menta BW, Manley SJ, Strope TA, Lysaker CR, Swerdlow RH. Mitochondrial Membrane Potential Influences Amyloid-β Protein Precursor Localization and Amyloid-β Secretion. Journal of Alzheimer's Disease : Jad. PMID 34806611 DOI: 10.3233/JAD-215280 |
0.822 |
|
| 2021 |
Morris JK, McCoin CS, Fuller KN, John CS, Wilkins HM, Green ZD, Wang X, Sharma P, Burns JM, Vidoni ED, Mahnken JD, Shankar K, Swerdlow RH, Thyfault JP. Mild Cognitive Impairment and Donepezil Impact Mitochondrial Respiratory Capacity in Skeletal Muscle. Function (Oxford, England). 2: zqab045. PMID 34661111 DOI: 10.1093/function/zqab045 |
0.768 |
|
| 2021 |
Paliwal D, McInerney TW, Pa J, Swerdlow RH, Easteal S, Andrews SJ. Mitochondrial pathway polygenic risk scores are associated with Alzheimer's Disease. Neurobiology of Aging. PMID 34521561 DOI: 10.1016/j.neurobiolaging.2021.08.005 |
0.382 |
|
| 2021 |
Wilkins HM, Swerdlow RH. Mitochondrial links between brain aging and Alzheimer's disease. Translational Neurodegeneration. 10: 33. PMID 34465385 DOI: 10.1186/s40035-021-00261-2 |
0.651 |
|
| 2021 |
Pope CA, Wilkins HM, Swerdlow RH, Wolfe MS. Mutations in the Amyloid-β Protein Precursor Reduce Mitochondrial Function and Alter Gene Expression Independent of 42-Residue Amyloid-β Peptide. Journal of Alzheimer's Disease : Jad. PMID 34366346 DOI: 10.3233/JAD-210366 |
0.631 |
|
| 2021 |
Tungtur SK, Wilkins HM, Rogers RS, Badawi Y, Sage JM, Agbas A, Jawdat O, Barohn RJ, Swerdlow RH, Nishimune H. Oxaloacetate treatment preserves motor function in SOD1 mice and normalizes select neuroinflammation-related parameters in the spinal cord. Scientific Reports. 11: 11051. PMID 34040085 DOI: 10.1038/s41598-021-90438-6 |
0.552 |
|
| 2021 |
Wilkins HM, Wang X, Menta BW, Koppel SJ, Bothwell R, Becker AM, Anderson H, Schwartz E, Pei D, Yellapu NK, Chalise P, Gouvion CM, Haeri M, Burns JM, Swerdlow RH. Bioenergetic and inflammatory systemic phenotypes in Alzheimer's disease APOE ε4-carriers. Aging Cell. e13356. PMID 33939248 DOI: 10.1111/acel.13356 |
0.823 |
|
| 2021 |
Swerdlow RH, de Leon MJ, Marcus DL. Betahydroxybutyrate Consumption in Autopsy Brain Tissue from Alzheimer's Disease Subjects. Journal of Alzheimer's Disease Reports. 5: 135-141. PMID 33782666 DOI: 10.3233/ADR-210002 |
0.315 |
|
| 2021 |
Koppel SJ, Pei D, Wilkins HM, Weidling IW, Wang X, Menta BW, Perez-Ortiz J, Kalani A, Manley S, Novikova L, Koestler DC, Swerdlow RH. A Ketogenic Diet Differentially Affects Neuron And Astrocyte Transcription. Journal of Neurochemistry. PMID 33539571 DOI: 10.1111/jnc.15313 |
0.791 |
|
| 2020 |
Flax J, Wilkins HM, Miller R, Griffith S, Cork GK, Qiang A, Thompson J, Swerdlow RH, Slawson C. OGA Inhibition Alters Energetics and Nutrient Sensing in Alzheimer's Disease Cytoplasmic Hybrids. Journal of Alzheimer's Disease : Jad. PMID 33285636 DOI: 10.3233/JAD-200996 |
0.69 |
|
| 2020 |
Wang X, Weidling I, Koppel S, Menta B, Perez Ortiz J, Kalani A, Wilkins HM, Swerdlow RH. Detection of Mitochondria-Pertinent Components in Exosomes. Mitochondrion. PMID 32980480 DOI: 10.1016/j.mito.2020.09.006 |
0.797 |
|
| 2020 |
Weidling IW, Wilkins HM, Koppel SJ, Hutfles L, Wang X, Kalani A, Menta BW, Ryan B, Perez-Ortiz J, Gamblin TC, Swerdlow RH. Mitochondrial DNA Manipulations Affect Tau Oligomerization. Journal of Alzheimer's Disease : Jad. PMID 32804126 DOI: 10.3233/Jad-200286 |
0.809 |
|
| 2020 |
Swerdlow RH. The mitochondrial hypothesis: Dysfunction, bioenergetic defects, and the metabolic link to Alzheimer's disease. International Review of Neurobiology. 154: 207-233. PMID 32739005 DOI: 10.1016/Bs.Irn.2020.01.008 |
0.534 |
|
| 2020 |
Vidoni ED, Choi IY, Lee P, Reed G, Zhang N, Pleen J, Mahnken JD, Clutton J, Becker A, Sherry E, Bothwell R, Anderson H, Harris RA, Brooks W, Wilkins HM, ... ... Swerdlow RH, et al. Safety and target engagement profile of two oxaloacetate doses in Alzheimer's patients. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 32715609 DOI: 10.1002/Alz.12156 |
0.653 |
|
| 2020 |
Cunnane SC, Trushina E, Morland C, Prigione A, Casadesus G, Andrews ZB, Beal MF, Bergersen LH, Brinton RD, de la Monte S, Eckert A, Harvey J, Jeggo R, Jhamandas JH, Kann O, ... ... Swerdlow RH, et al. Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing. Nature Reviews. Drug Discovery. PMID 32709961 DOI: 10.1038/S41573-020-0072-X |
0.391 |
|
| 2020 |
Swerdlow RH, Hui D, Chalise P, Sharma P, Wang X, Andrews SJ, Pa J, Mahnken JD, Morris J, Wilkins HM, Burns JM, Michaelis ML, Michaelis EK. Exploratory analysis of mtDNA haplogroups in two Alzheimer's longitudinal cohorts. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 32543785 DOI: 10.1002/Alz.12119 |
0.709 |
|
| 2020 |
Weidling IW, Swerdlow RH. Mitochondria in Alzheimer's disease and their potential role in Alzheimer's proteostasis. Experimental Neurology. 330: 113321. PMID 32339611 DOI: 10.1016/J.Expneurol.2020.113321 |
0.831 |
|
| 2020 |
Swerdlow RH. Mitochondria in Alzheimer brains: A PET project shows complex changes. Neurology. PMID 32139503 DOI: 10.1212/Wnl.0000000000009236 |
0.387 |
|
| 2019 |
Andrews SJ, Fulton-Howard B, Patterson C, McFall GP, Gross A, Michaelis EK, Goate A, Swerdlow RH, Pa J. Mitonuclear interactions influence Alzheimer's disease risk. Neurobiology of Aging. PMID 31784277 DOI: 10.1016/J.Neurobiolaging.2019.09.007 |
0.334 |
|
| 2019 |
Taylor MK, Swerdlow RH, Sullivan DK. Dietary Neuroketotherapeutics for Alzheimer's Disease: An Evidence Update and the Potential Role for Diet Quality. Nutrients. 11. PMID 31443216 DOI: 10.3390/Nu11081910 |
0.427 |
|
| 2019 |
Pa J, Andrews SJ, Swerdlow RH. Mitochondria and Alzheimer's: Is PTCD1 the Smoking Gun? Trends in Neurosciences. PMID 31421943 DOI: 10.1016/J.Tins.2019.08.003 |
0.434 |
|
| 2019 |
Tian J, Guo L, Sui S, Driskill C, Phensy A, Wang Q, Gauba E, Zigman JM, Swerdlow RH, Kroener S, Du H. Disrupted hippocampal growth hormone secretagogue receptor 1α interaction with dopamine receptor D1 plays a role in Alzheimer's disease. Science Translational Medicine. 11. PMID 31413143 DOI: 10.1126/Scitranslmed.Aav6278 |
0.372 |
|
| 2019 |
Watts A, Wilkins HM, Michaelis E, Swerdlow RH. TOMM40 '523 Associations with Baseline and Longitudinal Cognition in APOE ɛ3 Homozygotes. Journal of Alzheimer's Disease : Jad. PMID 31322569 DOI: 10.3233/Jad-190293 |
0.606 |
|
| 2019 |
Weidling I, Swerdlow RH. Mitochondrial Dysfunction and Stress Responses in Alzheimer's Disease. Biology. 8. PMID 31083585 DOI: 10.3390/Biology8020039 |
0.823 |
|
| 2019 |
Ji Y, Wang X, Kalicki C, Menta BW, Baumgardner M, Koppel SJ, Weidling IW, Perez-Ortiz J, Wilkins HM, Swerdlow RH. Effects of Microglial Cytokines on Alzheimer's Disease-Related Phenomena. Journal of Alzheimer's Disease : Jad. PMID 30714956 DOI: 10.3233/Jad-180820 |
0.799 |
|
| 2019 |
Perez Ortiz JM, Swerdlow RH. Mitochondrial dysfunction in Alzheimer's disease: Role in pathogenesis and novel therapeutic opportunities. British Journal of Pharmacology. PMID 30675901 DOI: 10.1111/bph.14585 |
0.428 |
|
| 2019 |
Morris JK, McCoin CS, Fuller KNZ, John CS, Wilkins HM, Wang X, Mahnken JD, Swerdlow RH, Thyfault JP. P1-197: Skeletal Muscle Mitochondrial Function In Cognitively Healthy Elderly And Mci Subjects Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.752 |
0.639 |
|
| 2019 |
Wilkins HM, Menta B, Weidling I, Koppel SJ, Swerdlow RH. P1-196: AMYLOID BETA AND BIOENERGETICS Alzheimer's & Dementia. 15: P312-P312. DOI: 10.1016/J.Jalz.2019.06.751 |
0.767 |
|
| 2019 |
Vidoni ED, Choi I, Lee P, Clutton J, Becker AM, Sherry E, Bothwell R, Anderson H, Mahnken JD, Wilkins HM, Brooks W, Reed G, Burns JM, Swerdlow RH. P3-008: TRIAL OF OXALOACETATE IN ALZHEIMER'S DISEASE (TOAD): FINAL RESULTS Alzheimer's & Dementia. 15: P927-P927. DOI: 10.1016/J.Jalz.2019.06.3034 |
0.642 |
|
| 2019 |
Wilkins HM, Wang X, Menta B, Koppel SJ, Bothwell R, Becker AM, Anderson H, Schwartz E, Sherry E, Burns JM, Swerdlow RH. P2-230: BIOENERGETIC BIOMARKERS IN APOE ε4-CARRIER AD SUBJECTS Alzheimer's & Dementia. 15: P667-P668. DOI: 10.1016/J.Jalz.2019.06.2637 |
0.8 |
|
| 2019 |
Choi I, Lee P, Vidoni ED, Clutton J, Becker AM, Sherry E, Bothwell R, Anderson H, Mahnken JD, Wilkins HM, Brooks W, Reed G, Burns JM, Swerdlow RH. P2-037: EFFECTS OF OXALOACETATE TREATMENTS ON CEREBRAL ANTIOXIDANT AND NEUROCHEMICAL PROFILE IN PATIENTS WITH ALZHEIMER'S DISEASE USING IN VIVO METABOLIC NEUROIMAGING Alzheimer's & Dementia. 15: P585-P586. DOI: 10.1016/J.Jalz.2019.06.1259 |
0.643 |
|
| 2018 |
Song H, Chen M, Chen C, Cui J, Johnson CE, Cheng J, Wang X, Swerdlow R, DePalma R, Xia W, Gu Z. Proteomic Analysis and Biochemical Correlates of Mitochondrial Dysfunction following Low-Intensity Primary Blast Exposure. Journal of Neurotrauma. PMID 30484371 DOI: 10.1089/Neu.2018.6114 |
0.696 |
|
| 2018 |
Kumar RP, Ray S, Home P, Saha B, Bhattacharya B, Wilkins HM, Chavan H, Ganguly A, Milano-Foster J, Paul A, Krishnamurthy P, Swerdlow RH, Paul S. Regulation of energy metabolism during early mammalian development: TEAD4 controls mitochondrial transcription. Development (Cambridge, England). PMID 30201685 DOI: 10.1242/Dev.162644 |
0.671 |
|
| 2018 |
Statland JM, Moore D, Wang Y, Walsh M, Mozaffar T, Elman L, Nations S, Mitsumoto H, Fernandes JA, Saperstein D, Hayat G, Herbelin L, Karam C, Katz J, Wilkins HM, ... ... Swerdlow RH, et al. Rasagiline for Amyotrophic Lateral Sclerosis: a Randomized Controlled Trial. Muscle & Nerve. PMID 30192007 DOI: 10.1002/Mus.26335 |
0.559 |
|
| 2018 |
Menta BW, Swerdlow RH. An Integrative Overview of Non-Amyloid and Non-Tau Pathologies in Alzheimer's Disease. Neurochemical Research. PMID 30084096 DOI: 10.1007/S11064-018-2603-Y |
0.81 |
|
| 2018 |
Taylor MK, Sullivan DK, Mahnken JD, Burns JM, Swerdlow RH. Feasibility and efficacy data from a ketogenic diet intervention in Alzheimer's disease. Alzheimer's & Dementia (New York, N. Y.). 4: 28-36. PMID 29955649 DOI: 10.1016/J.Trci.2017.11.002 |
0.321 |
|
| 2018 |
Mosconi L, Berti V, Quinn C, McHugh P, Petrongolo G, Osorio RS, Connaughty C, Pupi A, Vallabhajosula S, Isaacson RS, de Leon MJ, Swerdlow RH, Diaz Brinton R. Correction: Perimenopause and emergence of an Alzheimer's bioenergetic phenotype in brain and periphery. Plos One. 13: e0193314. PMID 29447296 DOI: 10.1371/Journal.Pone.0193314 |
0.326 |
|
| 2018 |
Andrews SJ, Swerdlow RH, McInerney T, Fulton-Howard B, Gross AL, McFall GP, Patterson C, Goate AM, Michaelis EK, Pa J, Initiative ADN. P4-244: Mitochondrial Haplogroups And A Nuclear Encoded Mitochondrial Polygenic Risk Score Interact To Influence Dementia Risk Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.07.065 |
0.402 |
|
| 2017 |
Connolly NMC, Theurey P, Adam-Vizi V, Bazan NG, Bernardi P, Bolaños JP, Culmsee C, Dawson VL, Deshmukh M, Duchen MR, Düssmann H, Fiskum G, Galindo MF, Hardingham GE, Hardwick JM, ... ... Swerdlow RH, et al. Guidelines on experimental methods to assess mitochondrial dysfunction in cellular models of neurodegenerative diseases. Cell Death and Differentiation. PMID 29229998 DOI: 10.1038/S41418-017-0020-4 |
0.456 |
|
| 2017 |
Taylor MK, Sullivan DK, Swerdlow RH, Vidoni ED, Morris JK, Mahnken JD, Burns JM. A high-glycemic diet is associated with cerebral amyloid burden in cognitively normal older adults. The American Journal of Clinical Nutrition. PMID 29070566 DOI: 10.3945/Ajcn.117.162263 |
0.317 |
|
| 2017 |
Swerdlow RH. Mitochondria and Mitochondrial Cascades in Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 29036828 DOI: 10.3233/Jad-170585 |
0.522 |
|
| 2017 |
Mosconi L, Berti V, Guyara-Quinn C, McHugh P, Petrongolo G, Osorio RS, Connaughty C, Pupi A, Vallabhajosula S, Isaacson RS, de Leon MJ, Swerdlow RH, Brinton RD. Perimenopause and emergence of an Alzheimer's bioenergetic phenotype in brain and periphery. Plos One. 12: e0185926. PMID 29016679 DOI: 10.1371/Journal.Pone.0185926 |
0.411 |
|
| 2017 |
Ma E, Chen P, Wilkins HM, Wang T, Swerdlow RH, Chen Q. Pharmacologic ascorbate induces neuroblastoma cell death by hydrogen peroxide mediated DNA damage and reduction in cancer cell glycolysis. Free Radical Biology & Medicine. PMID 28916476 DOI: 10.1016/J.Freeradbiomed.2017.09.008 |
0.618 |
|
| 2017 |
Wang X, Zhang Q, Bao R, Zhang N, Wang Y, Polo-Parada L, Tarim A, Alemifar A, Han X, Wilkins HM, Swerdlow RH, Wang X, Ding S. Deletion of Nampt in Projection Neurons of Adult Mice Leads to Motor Dysfunction, Neurodegeneration, and Death. Cell Reports. 20: 2184-2200. PMID 28854367 DOI: 10.1016/J.Celrep.2017.08.022 |
0.749 |
|
| 2017 |
Tan EP, McGreal SR, Graw S, Tessman R, Koppel SJ, Dhakal P, Zhang Z, Machacek M, Zachara NE, Koestler DC, Peterson KR, Thyfault JP, Swerdlow RH, Krishnamurthy P, DiTacchio L, et al. Sustained O-GlcNAcylation reprograms mitochondrial function to regulate energy metabolism. The Journal of Biological Chemistry. PMID 28739801 DOI: 10.1074/Jbc.M117.797944 |
0.74 |
|
| 2017 |
Sims R, van der Lee SJ, Naj AC, Bellenguez C, Badarinarayan N, Jakobsdottir J, Kunkle BW, Boland A, Raybould R, Bis JC, Martin ER, Grenier-Boley B, Heilmann-Heimbach S, Chouraki V, Kuzma AB, ... ... Swerdlow RH, et al. Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease. Nature Genetics. PMID 28714976 DOI: 10.1038/Ng.3916 |
0.333 |
|
| 2017 |
Wilkins HM, Mahnken JD, Welch P, Bothwell R, Koppel S, Jackson RL, Burns JM, Swerdlow RH. A Mitochondrial Biomarker-Based Study of S-Equol in Alzheimer's Disease Subjects: Results of a Single-Arm, Pilot Trial. Journal of Alzheimer's Disease : Jad. PMID 28598847 DOI: 10.3233/Jad-170077 |
0.839 |
|
| 2017 |
Koppel SJ, Swerdlow RH. Neuroketotherapeutics: A modern review of a century-old therapy. Neurochemistry International. PMID 28579059 DOI: 10.1016/J.Neuint.2017.05.019 |
0.733 |
|
| 2017 |
Hutfles LJ, Wilkins HM, Koppel SJ, Weidling IW, Selfridge JE, Tan E, Thyfault JP, Slawson C, Fenton AW, Zhu H, Swerdlow RH. A Bioenergetics Systems Evaluation of Ketogenic Diet Liver Effects. Applied Physiology, Nutrition, and Metabolism = Physiologie Appliquee, Nutrition Et Metabolisme. PMID 28514599 DOI: 10.1139/Apnm-2017-0068 |
0.775 |
|
| 2017 |
Wilkins HM, Weidling IW, Ji Y, Swerdlow RH. Mitochondria-Derived Damage-Associated Molecular Patterns in Neurodegeneration. Frontiers in Immunology. 8: 508. PMID 28491064 DOI: 10.3389/Fimmu.2017.00508 |
0.82 |
|
| 2017 |
Wilkins HM, Koppel SJ, Bothwell R, Mahnken J, Burns JM, Swerdlow RH. Platelet cytochrome oxidase and citrate synthase activities in APOE ε4 carrier and non-carrier Alzheimer's disease patients. Redox Biology. 12: 828-832. PMID 28448944 DOI: 10.1016/J.Redox.2017.04.010 |
0.816 |
|
| 2017 |
Swerdlow RH, Koppel S, Weidling I, Hayley C, Ji Y, Wilkins HM. Mitochondria, Cybrids, Aging, and Alzheimer's Disease. Progress in Molecular Biology and Translational Science. 146: 259-302. PMID 28253988 DOI: 10.1016/Bs.Pmbts.2016.12.017 |
0.846 |
|
| 2017 |
Morris JK, Vidoni ED, Johnson DK, Van Sciver A, Mahnken JD, Honea RA, Wilkins HM, Brooks WM, Billinger SA, Swerdlow RH, Burns JM. Aerobic exercise for Alzheimer's disease: A randomized controlled pilot trial. Plos One. 12: e0170547. PMID 28187125 DOI: 10.1371/Journal.Pone.0170547 |
0.629 |
|
| 2017 |
Chavan H, Christudoss P, Mickey K, Tessman R, Ni HM, Swerdlow R, Krishnamurthy P. Arsenite Effects on Mitochondrial Bioenergetics in Human and Mouse Primary Hepatocytes Follow a Nonlinear Dose Response. Oxidative Medicine and Cellular Longevity. 2017: 9251303. PMID 28163822 DOI: 10.1155/2017/9251303 |
0.322 |
|
| 2017 |
Swerdlow RH. THE KU ALZHEIMER'S DISEASE KETOGENIC DIET FEASIBILITY AND RETENTION TRIAL: RESULTS FROM A PILOT STUDY Alzheimer's & Dementia. 13: P883. DOI: 10.1016/J.Jalz.2017.07.275 |
0.324 |
|
| 2017 |
Wilkins HM, Koppel S, Bothwell R, Mahnken JD, Burns JM, Swerdlow RH. [P3-229]: PLATELET MITOCHONDRIA CYTOCHROME OXIDASE AND CITRATE SYNTHASE IN APOE4-CARRIER AD SUBJECTS Alzheimer's & Dementia. 13: P1026-P1026. DOI: 10.1016/J.Jalz.2017.06.1442 |
0.818 |
|
| 2016 |
Yu Q, Fang D, Swerdlow RH, Yu H, Chen JX, Yan SS. Antioxidants Rescue Mitochondrial Transport in Differentiated Alzheimer's Disease Trans-Mitochondrial Cybrid Cells. Journal of Alzheimer's Disease : Jad. PMID 27567872 DOI: 10.3233/Jad-160532 |
0.512 |
|
| 2016 |
Wilkins HM, Koppel SJ, Weidling IW, Roy N, Ryan LN, Stanford JA, Swerdlow RH. Extracellular Mitochondria and Mitochondrial Components Act as Damage-Associated Molecular Pattern Molecules in the Mouse Brain. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. PMID 27562848 DOI: 10.1007/S11481-016-9704-7 |
0.834 |
|
| 2016 |
Wilkins HM, Swerdlow RH. Amyloid Precursor Protein Processing and Bioenergetics. Brain Research Bulletin. PMID 27545490 DOI: 10.1016/J.Brainresbull.2016.08.009 |
0.69 |
|
| 2016 |
Morris JK, Vidoni ED, Wilkins HM, Archer AE, Burns NC, Karcher RT, Graves RS, Swerdlow RH, Thyfault JP, Burns JM. Impaired fasting glucose is associated with increased regional cerebral amyloid. Neurobiology of Aging. 44: 138-42. PMID 27318141 DOI: 10.1016/J.Neurobiolaging.2016.04.017 |
0.646 |
|
| 2016 |
He M, Singh P, Cheng S, Zhang Q, Peng W, Ding X, Li L, Liu J, Premont RT, Morgan D, Burns JM, Swerdlow RH, Suo WZ. GRK5 Deficiency Leads to Selective Basal Forebrain Cholinergic Neuronal Vulnerability. Scientific Reports. 6: 26116. PMID 27193825 DOI: 10.1038/Srep26116 |
0.346 |
|
| 2016 |
Swerdlow RH, Bothwell R, Hutfles L, Burns JM, Reed GA. Tolerability and pharmacokinetics of oxaloacetate 100 mg capsules in Alzheimer's subjects. Bba Clinical. 5: 120-3. PMID 27051598 DOI: 10.1016/J.Bbacli.2016.03.005 |
0.813 |
|
| 2016 |
Swerdlow RH. Rare ABCA7 variants in Alzheimer disease: Guilt by association. Neurology. PMID 27037231 DOI: 10.1212/Wnl.0000000000002630 |
0.354 |
|
| 2016 |
Weidling I, Swerdlow RH. The ABCD's of 5'-adenosine monophosphate-activated protein kinase and adrenoleukodystrophy. Journal of Neurochemistry. PMID 26990533 DOI: 10.1111/Jnc.13594 |
0.738 |
|
| 2016 |
Swerdlow RH. Bioenergetics and metabolism: a bench to bedside perspective. Journal of Neurochemistry. PMID 26968700 DOI: 10.1111/Jnc.13509 |
0.345 |
|
| 2016 |
Wilkins HM, Koppel S, Carl SM, Ramanujan S, Weidling I, Michaelis ML, Michaelis EK, Swerdlow RH. Oxaloacetate Enhances Neuronal Cell Bioenergetic Fluxes and Infrastructure. Journal of Neurochemistry. PMID 26811028 DOI: 10.1111/Jnc.13545 |
0.804 |
|
| 2016 |
E L, Swerdlow RH. Lactate's effect on human neuroblastoma cell bioenergetic fluxes. Biochemical Pharmacology. 99: 88-100. PMID 26592660 DOI: 10.1016/J.Bcp.2015.11.002 |
0.726 |
|
| 2016 |
Wilkins HM, Swerdlow RH. Relationships Between Mitochondria and Neuroinflammation: Implications for Alzheimer's Disease. Current Topics in Medicinal Chemistry. 16: 849-57. PMID 26311426 DOI: 10.2174/1568026615666150827095102 |
0.73 |
|
| 2016 |
Wilkins HM, Weidling I, Carl SM, Ramanujan S, Weber SG, Swerdlow RH. P4-067: Influence of Cell Bioenergetics on App Processing Alzheimer's & Dementia. 12: P1039-P1039. DOI: 10.1016/J.Jalz.2016.06.2157 |
0.78 |
|
| 2016 |
Wilkins HM, Welch P, Koppel S, Bothwell R, Mahnken JD, Burns JM, Swerdlow RH. P3-026: Trial of S-Equol in Alzheimer’s Disease (SEAD) Alzheimer's & Dementia. 12: P827-P827. DOI: 10.1016/J.Jalz.2016.06.1683 |
0.781 |
|
| 2016 |
Wilkins HM, Koppel S, Roy N, Ryan L, Stanford JA, Swerdlow RH. P2-128: Mitochondria and Mitochondrial DNA Induce Neuroinflammation and Alter app Homeostasis Alzheimer's & Dementia. 12: P660-P661. DOI: 10.1016/J.Jalz.2016.06.1498 |
0.822 |
|
| 2016 |
Morris JK, Vidoni ED, Wilkins HM, Swerdlow RH, Burns JM. P2-094: Relationship Between Apolipoprotein E4 Genotype and Whole Body Aerobic Capacity Alzheimer's & Dementia. 12: P646-P647. DOI: 10.1016/J.Jalz.2016.06.1299 |
0.585 |
|
| 2015 |
Swerdlow RH. Mitochondrial Manipulation and the Quest for Alzheimer's Treatments. Ebiomedicine. 2: 276-7. PMID 26137567 DOI: 10.1016/J.Ebiom.2015.03.017 |
0.465 |
|
| 2015 |
Macchi Z, Wang Y, Moore D, Katz J, Saperstein D, Walk D, Simpson E, Genge A, Bertorini T, Fernandes JA, Swenson A, Elman L, Dimachkie M, Herbelin L, Miller J, ... ... Swerdlow RH, et al. A multi-center screening trial of rasagiline in patients with amyotrophic lateral sclerosis: Possible mitochondrial biomarker target engagement. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 1-8. PMID 25832828 DOI: 10.3109/21678421.2015.1026826 |
0.631 |
|
| 2015 |
Wilkins HM, Swerdlow RH. TNFα in cerebral ischemia: another stroke against you? Journal of Neurochemistry. 132: 369-72. PMID 25656781 DOI: 10.1111/Jnc.13028 |
0.568 |
|
| 2015 |
Arduíno DM, Esteves AR, Swerdlow RH, Cardoso SM. A cybrid cell model for the assessment of the link between mitochondrial deficits and sporadic Parkinson's disease. Methods in Molecular Biology (Clifton, N.J.). 1265: 415-24. PMID 25634293 DOI: 10.1007/978-1-4939-2288-8_31 |
0.366 |
|
| 2015 |
Wilkins HM, Carl SM, Weber SG, Ramanujan SA, Festoff BW, Linseman DA, Swerdlow RH. Mitochondrial lysates induce inflammation and Alzheimer's disease-relevant changes in microglial and neuronal cells. Journal of Alzheimer's Disease : Jad. 45: 305-18. PMID 25537010 DOI: 10.3233/Jad-142334 |
0.843 |
|
| 2015 |
Selfridge JE, Wilkins HM, E L, Carl SM, Koppel S, Funk E, Fields T, Lu J, Tang EP, Slawson C, Wang W, Zhu H, Swerdlow RH. Effect of one month duration ketogenic and non-ketogenic high fat diets on mouse brain bioenergetic infrastructure. Journal of Bioenergetics and Biomembranes. 47: 1-11. PMID 25104046 DOI: 10.1007/S10863-014-9570-Z |
0.773 |
|
| 2015 |
Wilkins HM, Carl SM, Ramanujan S, Weber SG, Swerdlow RH. P3-023: Influence of mitochondrial function and cell bioenergetics on app processing Alzheimer's & Dementia. 11: P628-P628. DOI: 10.1016/J.Jalz.2015.06.889 |
0.821 |
|
| 2015 |
Wilkins HM, Roy N, Stanford JA, Swerdlow RH. P4-024: Injecting mitochondria into mouse hippocampi induces neuroinflammation and raises app expression Alzheimer's & Dementia. 11: P774-P775. DOI: 10.1016/J.Jalz.2015.06.1728 |
0.803 |
|
| 2014 |
Wilkins HM, Carl SM, Swerdlow RH. Cytoplasmic hybrid (cybrid) cell lines as a practical model for mitochondriopathies. Redox Biology. 2: 619-631. PMID 25460729 DOI: 10.1016/J.Redox.2014.03.006 |
0.799 |
|
| 2014 |
Wilkins HM, Carl SM, Greenlief AC, Festoff BW, Swerdlow RH. Bioenergetic dysfunction and inflammation in Alzheimer's disease: a possible connection. Frontiers in Aging Neuroscience. 6: 311. PMID 25426068 DOI: 10.3389/Fnagi.2014.00311 |
0.818 |
|
| 2014 |
Mahato B, Home P, Rajendran G, Paul A, Saha B, Ganguly A, Ray S, Roy N, Swerdlow RH, Paul S. Regulation of mitochondrial function and cellular energy metabolism by protein kinase C-λ/ι: a novel mode of balancing pluripotency. Stem Cells (Dayton, Ohio). 32: 2880-92. PMID 25142417 DOI: 10.1002/Stem.1817 |
0.794 |
|
| 2014 |
Wilkins HM, Harris JL, Carl SM, E L, Lu J, Eva Selfridge J, Roy N, Hutfles L, Koppel S, Morris J, Burns JM, Michaelis ML, Michaelis EK, Brooks WM, Swerdlow RH. Oxaloacetate activates brain mitochondrial biogenesis, enhances the insulin pathway, reduces inflammation and stimulates neurogenesis. Human Molecular Genetics. 23: 6528-41. PMID 25027327 DOI: 10.1093/Hmg/Ddu371 |
0.8 |
|
| 2014 |
E L, Burns JM, Swerdlow RH. Effect of high-intensity exercise on aged mouse brain mitochondria, neurogenesis, and inflammation. Neurobiology of Aging. 35: 2574-83. PMID 25002036 DOI: 10.1016/j.neurobiolaging.2014.05.033 |
0.683 |
|
| 2014 |
Esteves AR, Swerdlow RH, Cardoso SM. LRRK2, a puzzling protein: insights into Parkinson's disease pathogenesis. Experimental Neurology. 261: 206-16. PMID 24907399 DOI: 10.1016/J.Expneurol.2014.05.025 |
0.341 |
|
| 2014 |
Morris JK, Honea RA, Vidoni ED, Swerdlow RH, Burns JM. Is Alzheimer's disease a systemic disease? Biochimica Et Biophysica Acta. 1842: 1340-9. PMID 24747741 DOI: 10.1016/J.Bbadis.2014.04.012 |
0.409 |
|
| 2014 |
Tan EP, Villar MT, E L, Lu J, Selfridge JE, Artigues A, Swerdlow RH, Slawson C. Altering O-linked β-N-acetylglucosamine cycling disrupts mitochondrial function. The Journal of Biological Chemistry. 289: 14719-30. PMID 24713701 DOI: 10.1074/jbc.M113.525790 |
0.816 |
|
| 2014 |
Harris JL, Yeh HW, Swerdlow RH, Choi IY, Lee P, Brooks WM. High-field proton magnetic resonance spectroscopy reveals metabolic effects of normal brain aging. Neurobiology of Aging. 35: 1686-94. PMID 24559659 DOI: 10.1016/J.Neurobiolaging.2014.01.018 |
0.309 |
|
| 2014 |
Stroh M, Swerdlow RH, Zhu H. Common defects of mitochondria and iron in neurodegeneration and diabetes (MIND): a paradigm worth exploring. Biochemical Pharmacology. 88: 573-83. PMID 24361914 DOI: 10.1016/J.Bcp.2013.11.022 |
0.31 |
|
| 2014 |
Gan X, Huang S, Wu L, Wang Y, Hu G, Li G, Zhang H, Yu H, Swerdlow RH, Chen JX, Yan SS. Inhibition of ERK-DLP1 signaling and mitochondrial division alleviates mitochondrial dysfunction in Alzheimer's disease cybrid cell Biochimica Et Biophysica Acta - Molecular Basis of Disease. 1842: 220-231. PMID 24252614 DOI: 10.1016/J.Bbadis.2013.11.009 |
0.525 |
|
| 2014 |
Dai Y, Zheng K, Clark J, Swerdlow RH, Pulst SM, Sutton JP, Shinobu LA, Simon DK. Rapamycin drives selection against a pathogenic heteroplasmic mitochondrial DNA mutation. Human Molecular Genetics. 23: 637-47. PMID 24101601 DOI: 10.1093/Hmg/Ddt450 |
0.385 |
|
| 2014 |
Swerdlow RH, Burns JM, Khan SM. The Alzheimer's disease mitochondrial cascade hypothesis: progress and perspectives. Biochimica Et Biophysica Acta. 1842: 1219-31. PMID 24071439 DOI: 10.1016/J.Bbadis.2013.09.010 |
0.533 |
|
| 2014 |
E L, Swerdlow RH, Burns JM. P1-417: VIGOROUS EXERCISE AFFECTS BRAIN MITOCHONDRIA, NEUROGENESIS, AND INFLAMMATION-RELATED PARAMETERS IN AGED MICE Alzheimer's & Dementia. 10: P466-P467. DOI: 10.1016/J.Jalz.2014.05.660 |
0.331 |
|
| 2014 |
Wilkins HM, Swerdlow RH, Carl S, Harris J, Lu J, Koppel S, E L, Selfridge E, Hutfles L, Roy N, Burns JM, Brooks WM, Michaelis M, Michaelis E. P4-199: IMPACT OF OXALOACETATE ON BRAIN BIOENERGETIC INFRASTRUCTURES, NEUROGENESIS, AND INFLAMMATION Alzheimer's & Dementia. 10: P861-P861. DOI: 10.1016/J.Jalz.2014.05.1716 |
0.765 |
|
| 2014 |
Newell K, Vonsattel JP, Murrell J, Ghetti BF, Gambetti P, Dubinsky R, Swerdlow RH. P4-147: PHENOTYPIC CHARACTERIZATION OF EARLY ONSET FAMILIAL AD ASSOCIATED WITH A PSEN1 L418F MUTATION Alzheimer's & Dementia. 10: P842-P843. DOI: 10.1016/J.Jalz.2014.05.1663 |
0.319 |
|
| 2013 |
Ridge PG, Koop A, Maxwell TJ, Bailey MH, Swerdlow RH, Kauwe JS, Honea RA. Mitochondrial haplotypes associated with biomarkers for Alzheimer's disease. Plos One. 8: e74158. PMID 24040196 DOI: 10.1371/Journal.Pone.0074158 |
0.464 |
|
| 2013 |
E L, Lu J, Selfridge JE, Burns JM, Swerdlow RH. Lactate administration reproduces specific brain and liver exercise-related changes. Journal of Neurochemistry. 127: 91-100. PMID 23927032 DOI: 10.1111/jnc.12394 |
0.787 |
|
| 2013 |
Herrup K, Carrillo MC, Schenk D, Cacace A, Desanti S, Fremeau R, Bhat R, Glicksman M, May P, Swerdlow R, Van Eldik LJ, Bain LJ, Budd S. Beyond amyloid: getting real about nonamyloid targets in Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 9: 452-458.e1. PMID 23809366 DOI: 10.1016/J.Jalz.2013.01.017 |
0.408 |
|
| 2013 |
Silva DF, Selfridge JE, Lu J, E L, Roy N, Hutfles L, Burns JM, Michaelis EK, Yan S, Cardoso SM, Swerdlow RH. Bioenergetic flux, mitochondrial mass and mitochondrial morphology dynamics in AD and MCI cybrid cell lines. Human Molecular Genetics. 22: 3931-46. PMID 23740939 DOI: 10.1093/Hmg/Ddt247 |
0.828 |
|
| 2013 |
Burns JM, Swerdlow RH. Backwaters and rapids on the amyloid river. Neurology. 80: 878-9. PMID 23446682 DOI: 10.1212/Wnl.0B013E3182840D14 |
0.382 |
|
| 2013 |
Swerdlow RH, E L, Aires D, Lu J. Glycolysis-respiration relationships in a neuroblastoma cell line. Biochimica Et Biophysica Acta. 1830: 2891-8. PMID 23313167 DOI: 10.1016/j.bbagen.2013.01.002 |
0.7 |
|
| 2013 |
Lu J, E L, Roy N, Hutfles L, Selfridge E, Funk E, Burns JM, Swerdlow RH. Effect of cholinergic signaling on neuronal cell bioenergetics. Journal of Alzheimer's Disease : Jad. 33: 1135-46. PMID 23099815 DOI: 10.3233/Jad-2012-121822 |
0.814 |
|
| 2013 |
E L, Lu J, Burns JM, Swerdlow RH. Effect of exercise on mouse liver and brain bioenergetic infrastructures. Experimental Physiology. 98: 207-19. PMID 22613742 DOI: 10.1113/expphysiol.2012.066688 |
0.694 |
|
| 2013 |
Selfridge JE, E L, Lu J, Swerdlow RH. Role of mitochondrial homeostasis and dynamics in Alzheimer's disease. Neurobiology of Disease. 51: 3-12. PMID 22266017 DOI: 10.1016/j.nbd.2011.12.057 |
0.847 |
|
| 2013 |
Honea R, Cruchaga C, Perea R, Swerdlow R, Weinberger D, Saykin A, Goate A. P1-281: Role of genetic variation on longitudinal imaging measures of Alzheimer's disease in the ADNI Cohort Alzheimer's & Dementia. 9: P257-P257. DOI: 10.1016/J.Jalz.2013.05.506 |
0.318 |
|
| 2013 |
Ridge P, Koop A, Maxwell T, Swerdlow R, Kauwe J, Honea R. P1-154: Mitochondrial genetic variation is associated with brain imaging markers of Alzheimer's disease neurodegeneration Alzheimer's & Dementia. 9: P206-P206. DOI: 10.1016/J.Jalz.2013.05.377 |
0.445 |
|
| 2012 |
Swerdlow RH, Newell KL. "Untangling" the relationship between Alzheimer disease and dementia with Lewy bodies. Neurology. 79: 1938-9. PMID 23035062 DOI: 10.1212/Wnl.0B013E3182735Ecf |
0.302 |
|
| 2012 |
Martins-Branco D, Esteves AR, Santos D, Arduino DM, Swerdlow RH, Oliveira CR, Januario C, Cardoso SM. Ubiquitin proteasome system in Parkinson's disease: a keeper or a witness? Experimental Neurology. 238: 89-99. PMID 22921536 DOI: 10.7490/F1000Research.1092129.1 |
0.323 |
|
| 2012 |
Harris JL, Yeh HW, Choi IY, Lee P, Berman NE, Swerdlow RH, Craciunas SC, Brooks WM. Altered neurochemical profile after traumatic brain injury: (1)H-MRS biomarkers of pathological mechanisms. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 32: 2122-34. PMID 22892723 DOI: 10.1038/Jcbfm.2012.114 |
0.313 |
|
| 2012 |
Arduíno DM, Esteves AR, Cortes L, Silva DF, Patel B, Grazina M, Swerdlow RH, Oliveira CR, Cardoso SM. Mitochondrial metabolism in Parkinson's disease impairs quality control autophagy by hampering microtubule-dependent traffic. Human Molecular Genetics. 21: 4680-702. PMID 22843496 DOI: 10.1093/Hmg/Dds309 |
0.4 |
|
| 2012 |
Silva DF, Selfridge JE, Lu J, E L, Cardoso SM, Swerdlow RH. Mitochondrial abnormalities in Alzheimer's disease: possible targets for therapeutic intervention. Advances in Pharmacology (San Diego, Calif.). 64: 83-126. PMID 22840745 DOI: 10.1016/B978-0-12-394816-8.00003-9 |
0.842 |
|
| 2012 |
Swerdlow RH, Corder EH. For Alzheimer disease GWAS, pulling needles from the haystack is just the first step. Neurology. 79: 204-5. PMID 22722635 DOI: 10.1212/Wnl.0B013E318260581D |
0.317 |
|
| 2012 |
Honea RA, Vidoni ED, Swerdlow RH, Burns JM. Maternal family history is associated with Alzheimer's disease biomarkers. Journal of Alzheimer's Disease : Jad. 31: 659-68. PMID 22669011 DOI: 10.3233/Jad-2012-120676 |
0.333 |
|
| 2012 |
Lezi E, Swerdlow RH. Mitochondria in neurodegeneration. Advances in Experimental Medicine and Biology. 942: 269-86. PMID 22399427 DOI: 10.1007/978-94-007-2869-1_12 |
0.485 |
|
| 2012 |
Aires DJ, Rockwell G, Wang T, Frontera J, Wick J, Wang W, Tonkovic-Capin M, Lu J, E L, Zhu H, Swerdlow RH. Potentiation of dietary restriction-induced lifespan extension by polyphenols. Biochimica Et Biophysica Acta. 1822: 522-6. PMID 22265987 DOI: 10.1016/J.Bbadis.2012.01.005 |
0.696 |
|
| 2012 |
Swerdlow RH. β-Apptists and Tauists, it is time for a sermon from the book of biogenesis. Journal of Neurochemistry. 120: 347-9. PMID 22035261 DOI: 10.1111/J.1471-4159.2011.07561.X |
0.503 |
|
| 2012 |
Swerdlow RH. Alzheimer's disease pathologic cascades: who comes first, what drives what. Neurotoxicity Research. 22: 182-94. PMID 21913048 DOI: 10.1007/S12640-011-9272-9 |
0.473 |
|
| 2012 |
Swerdlow RH. Mitochondria and cell bioenergetics: increasingly recognized components and a possible etiologic cause of Alzheimer's disease. Antioxidants & Redox Signaling. 16: 1434-55. PMID 21902597 DOI: 10.1089/Ars.2011.4149 |
0.469 |
|
| 2012 |
Burns JM, Honea RA, Vidoni ED, Hutfles LJ, Brooks WM, Swerdlow RH. Insulin is differentially related to cognitive decline and atrophy in Alzheimer's disease and aging. Biochimica Et Biophysica Acta. 1822: 333-9. PMID 21745566 DOI: 10.1016/J.Bbadis.2011.06.011 |
0.793 |
|
| 2012 |
Vidoni ED, Honea RA, Billinger SA, Swerdlow RH, Burns JM. Cardiorespiratory fitness is associated with atrophy in Alzheimer's and aging over 2 years. Neurobiology of Aging. 33: 1624-32. PMID 21531480 DOI: 10.1016/J.Neurobiolaging.2011.03.016 |
0.359 |
|
| 2012 |
Swerdlow RH. Does mitochondrial DNA play a role in Parkinson's disease? A review of cybrid and other supportive evidence. Antioxidants & Redox Signaling. 16: 950-64. PMID 21338319 DOI: 10.1089/Ars.2011.3948 |
0.349 |
|
| 2012 |
Honea R, Vidoni E, Swerdlow R, Burns J. P4-131: Association of maternal family history of dementia with Alzheimer's disease biomarkers Alzheimer's & Dementia. 8: P677-P677. DOI: 10.1016/J.Jalz.2012.05.1834 |
0.333 |
|
| 2011 |
Swerdlow RH. Brain aging, Alzheimer's disease, and mitochondria. Biochimica Et Biophysica Acta. 1812: 1630-9. PMID 21920438 DOI: 10.1016/J.Bbadis.2011.08.012 |
0.405 |
|
| 2011 |
Swerdlow RH. Role and treatment of mitochondrial DNA-related mitochondrial dysfunction in sporadic neurodegenerative diseases. Current Pharmaceutical Design. 17: 3356-73. PMID 21902672 DOI: 10.2174/138161211798072535 |
0.451 |
|
| 2011 |
Mosconi L, de Leon M, Murray J, E L, Lu J, Javier E, McHugh P, Swerdlow RH. Reduced mitochondria cytochrome oxidase activity in adult children of mothers with Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 27: 483-90. PMID 21841246 DOI: 10.3233/Jad-2011-110866 |
0.728 |
|
| 2011 |
Honea RA, Swerdlow RH, Vidoni ED, Burns JM. Progressive regional atrophy in normal adults with a maternal history of Alzheimer disease. Neurology. 76: 822-9. PMID 21357834 DOI: 10.1212/Wnl.0B013E31820E7B74 |
0.374 |
|
| 2011 |
Lu J, E L, Wang W, Frontera J, Zhu H, Wang WT, Lee P, Choi IY, Brooks WM, Burns JM, Aires D, Swerdlow RH. Alternate day fasting impacts the brain insulin-signaling pathway of young adult male C57BL/6 mice. Journal of Neurochemistry. 117: 154-63. PMID 21244426 DOI: 10.1111/J.1471-4159.2011.07184.X |
0.714 |
|
| 2010 |
Onyango IG, Ahn JY, Tuttle JB, Bennett JP, Swerdlow RH. Nerve growth factor attenuates oxidant-induced β-amyloid neurotoxicity in sporadic Alzheimer's disease cybrids. Journal of Neurochemistry. 114: 1605-18. PMID 20561151 DOI: 10.1111/J.1471-4159.2010.06871.X |
0.45 |
|
| 2010 |
Esteves AR, Arduíno DM, Swerdlow RH, Oliveira CR, Cardoso SM. Microtubule depolymerization potentiates alpha-synuclein oligomerization. Frontiers in Aging Neuroscience. 1: 5. PMID 20552056 DOI: 10.3389/Neuro.24.005.2009 |
0.335 |
|
| 2010 |
Swerdlow RH, Burns JM, Khan SM. The Alzheimer's disease mitochondrial cascade hypothesis. Journal of Alzheimer's Disease : Jad. 20: S265-79. PMID 20442494 DOI: 10.3233/Jad-2010-100339 |
0.52 |
|
| 2010 |
Lu J, Wang K, Rodova M, Esteves R, Berry D, E L, Crafter A, Barrett M, Cardoso SM, Onyango I, Parker WD, Fontes J, Burns JM, Swerdlow RH. Polymorphic variation in cytochrome oxidase subunit genes. Journal of Alzheimer's Disease : Jad. 21: 141-54. PMID 20413852 DOI: 10.3233/Jad-2010-100123 |
0.694 |
|
| 2010 |
Burns JM, Johnson DK, Watts A, Swerdlow RH, Brooks WM. Reduced lean mass in early Alzheimer disease and its association with brain atrophy. Archives of Neurology. 67: 428-33. PMID 20385908 DOI: 10.1001/Archneurol.2010.38 |
0.369 |
|
| 2010 |
Mosconi L, Berti V, Swerdlow RH, Pupi A, Duara R, de Leon M. Maternal transmission of Alzheimer's disease: prodromal metabolic phenotype and the search for genes. Human Genomics. 4: 170-93. PMID 20368139 DOI: 10.1186/1479-7364-4-3-170 |
0.391 |
|
| 2010 |
Swerdlow RH. An Alzheimer disease presenilin mutation, syndrome diversity, and a shrinking world. Neurology. 74: 790-1. PMID 20164096 DOI: 10.1212/Wnl.0B013E3181D3E429 |
0.311 |
|
| 2010 |
Esteves AR, Lu J, Rodova M, Onyango I, Lezi E, Dubinsky R, Lyons KE, Pahwa R, Burns JM, Cardoso SM, Swerdlow RH. Mitochondrial respiration and respiration-associated proteins in cell lines created through Parkinson's subject mitochondrial transfer. Journal of Neurochemistry. 113: 674-82. PMID 20132468 DOI: 10.1111/J.1471-4159.2010.06631.X |
0.34 |
|
| 2010 |
Honea RA, Swerdlow RH, Vidoni ED, Goodwin J, Burns JM. Reduced gray matter volume in normal adults with a maternal family history of Alzheimer disease. Neurology. 74: 113-20. PMID 20065246 DOI: 10.1212/Wnl.0B013E3181C918Cb |
0.363 |
|
| 2010 |
Esteves AR, Arduíno DM, Swerdlow RH, Oliveira CR, Cardoso SM. Dysfunctional mitochondria uphold calpain activation: contribution to Parkinson's disease pathology. Neurobiology of Disease. 37: 723-30. PMID 20034566 DOI: 10.1016/J.Nbd.2009.12.011 |
0.409 |
|
| 2010 |
Zhang L, Yu C, Vasquez FE, Galeva N, Onyango I, Swerdlow RH, Dobrowsky RT. Hyperglycemia alters the schwann cell mitochondrial proteome and decreases coupled respiration in the absence of superoxide production. Journal of Proteome Research. 9: 458-71. PMID 19905032 DOI: 10.1021/Pr900818G |
0.454 |
|
| 2010 |
Onyango IG, Lu J, Rodova M, Lezi E, Crafter AB, Swerdlow RH. Regulation of neuron mitochondrial biogenesis and relevance to brain health. Biochimica Et Biophysica Acta. 1802: 228-34. PMID 19682571 DOI: 10.1016/J.Bbadis.2009.07.014 |
0.474 |
|
| 2010 |
Honea RA, Swerdlow RH, Vidoni ED, Burns JM. Maternal Family History of Alzheimer's Disease Predisposes to Increased Rate of Hippocampal Atrophy: an ADNI Study Alzheimer's & Dementia. 6: S299. DOI: 10.1016/J.Jalz.2010.05.977 |
0.31 |
|
| 2009 |
Swerdlow RH. Mitochondrial Medicine and the Neurodegenerative Mitochondriopathies. Pharmaceuticals (Basel, Switzerland). 2: 150-167. PMID 21814473 DOI: 10.3390/Ph2030150 |
0.422 |
|
| 2009 |
Swerdlow RH. The neurodegenerative mitochondriopathies. Journal of Alzheimer's Disease : Jad. 17: 737-51. PMID 19542616 DOI: 10.3233/Jad-2009-1095 |
0.435 |
|
| 2009 |
Swerdlow RH, Khan SM. The Alzheimer's disease mitochondrial cascade hypothesis: an update. Experimental Neurology. 218: 308-15. PMID 19416677 DOI: 10.1016/J.Expneurol.2009.01.011 |
0.52 |
|
| 2009 |
Esteves AR, Arduíno DM, Swerdlow RH, Oliveira CR, Cardoso SM. Oxidative stress involvement in alpha-synuclein oligomerization in Parkinson's disease cybrids. Antioxidants & Redox Signaling. 11: 439-48. PMID 18717628 DOI: 10.1089/Ars.2008.2247 |
0.317 |
|
| 2009 |
Swerdlow R, Onyango I, Anderson H, Brooks W, Burns J. Systemic metabolic abnormalities in Alzheimer's disease Journal of the Neurological Sciences. 283: 272. DOI: 10.1016/J.Jns.2009.02.127 |
0.336 |
|
| 2008 |
Burns JM, Cronk BB, Anderson HS, Donnelly JE, Thomas GP, Harsha A, Brooks WM, Swerdlow RH. Cardiorespiratory fitness and brain atrophy in early Alzheimer disease. Neurology. 71: 210-6. PMID 18625967 DOI: 10.1212/01.Wnl.0000317094.86209.Cb |
0.402 |
|
| 2008 |
Domingues AF, Arduíno DM, Esteves AR, Swerdlow RH, Oliveira CR, Cardoso SM. Mitochondria and ubiquitin-proteasomal system interplay: relevance to Parkinson's disease. Free Radical Biology & Medicine. 45: 820-5. PMID 18619530 DOI: 10.1016/J.Freeradbiomed.2008.06.007 |
0.455 |
|
| 2008 |
Esteves AR, Domingues AF, Ferreira IL, Januário C, Swerdlow RH, Oliveira CR, Cardoso SM. Mitochondrial function in Parkinson's disease cybrids containing an nt2 neuron-like nuclear background. Mitochondrion. 8: 219-28. PMID 18495557 DOI: 10.1016/J.Mito.2008.03.004 |
0.36 |
|
| 2008 |
Domingues AF, Esteves AR, Swerdlow RH, Oliveira CR, Cardoso SM. Calpain-mediated MPP+ toxicity in mitochondrial DNA depleted cells. Neurotoxicity Research. 13: 31-8. PMID 18367438 DOI: 10.1007/Bf03033365 |
0.375 |
|
| 2008 |
McAllister J, Ghosh S, Berry D, Park M, Sadeghi S, Wang KX, Parker WD, Swerdlow RH. Effects of memantine on mitochondrial function. Biochemical Pharmacology. 75: 956-64. PMID 18053965 DOI: 10.1016/J.Bcp.2007.10.019 |
0.402 |
|
| 2008 |
Burns JM, Cronk B, Brooks W, Swerdlow R. IC-P1-005: Lean mass is associated with cognition and brain atrophy in early Alzheimer's disease Alzheimer's & Dementia. 4: T11-T12. DOI: 10.1016/J.Jalz.2008.05.018 |
0.349 |
|
| 2007 |
Swerdlow RH. PET sheds light on Alzheimer's disease genetic risk. Proceedings of the National Academy of Sciences of the United States of America. 104: 18881-2. PMID 18025455 DOI: 10.1073/Pnas.0709690104 |
0.364 |
|
| 2007 |
Swerdlow RH. Treating neurodegeneration by modifying mitochondria: potential solutions to a "complex" problem. Antioxidants & Redox Signaling. 9: 1591-603. PMID 17663643 DOI: 10.1089/Ars.2007.1676 |
0.358 |
|
| 2007 |
Ghosh S, Patel N, Rahn D, McAllister J, Sadeghi S, Horwitz G, Berry D, Kai XW, Swerdlow RH. The thiazolidinedione pioglitazone alters mitochondrial function in human neuron-like cells Molecular Pharmacology. 71: 1695-1702. PMID 17387142 DOI: 10.1124/Mol.106.033845 |
0.453 |
|
| 2007 |
Swerdlow RH. Mitochondria in cybrids containing mtDNA from persons with mitochondriopathies. Journal of Neuroscience Research. 85: 3416-28. PMID 17243174 DOI: 10.1002/Jnr.21167 |
0.381 |
|
| 2007 |
Khan SM, Smigrodzki RM, Swerdlow RH. Cell and animal models of mtDNA biology: progress and prospects. American Journal of Physiology. Cell Physiology. 292: C658-69. PMID 16899549 DOI: 10.1152/Ajpcell.00224.2006 |
0.371 |
|
| 2007 |
Swerdlow RH. Is aging part of Alzheimer's disease, or is Alzheimer's disease part of aging? Neurobiology of Aging. 28: 1465-80. PMID 16876913 DOI: 10.1016/J.Neurobiolaging.2006.06.021 |
0.396 |
|
| 2006 |
Onyango I, Khan S, Miller B, Swerdlow R, Trimmer P, Bennett P. Mitochondrial genomic contribution to mitochondrial dysfunction in Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 9: 183-93. PMID 16873965 DOI: 10.3233/Jad-2006-9210 |
0.539 |
|
| 2006 |
Cunha-Oliveira T, Rego AC, Cardoso SM, Borges F, Swerdlow RH, Macedo T, de Oliveira CR. Mitochondrial dysfunction and caspase activation in rat cortical neurons treated with cocaine or amphetamine. Brain Research. 1089: 44-54. PMID 16638611 DOI: 10.1016/J.Brainres.2006.03.061 |
0.341 |
|
| 2006 |
Swerdlow RH, Redpath GT, Binder DR, Davis JN, VandenBerg SR. Mitochondrial DNA depletion analysis by pseudogene ratioing. Journal of Neuroscience Methods. 150: 265-71. PMID 16118020 DOI: 10.1016/J.Jneumeth.2005.06.023 |
0.385 |
|
| 2006 |
Wilkins HM, Wang X, Koppel SJ, Bothwell R, Becker AM, Anderson H, Sherry E, Burns JM, Swerdlow RH. P2-282: PLATELET AND LYMPHOCYTE MITOCHONDRIAL BIOMARKERS IN APOE ε4-CARRIER AD SUBJECTS Alzheimer's & Dementia. 14: P788-P789. DOI: 10.1016/J.Jalz.2018.06.971 |
0.826 |
|
| 2006 |
Koppel SJ, Wilkins HM, Weidling I, Swerdlow RH. P2-149: EFFECT OF β-HYDROXYBUTYRATE ON NEURONS AND ASTROCYTES Alzheimer's & Dementia. 14: P725-P725. DOI: 10.1016/J.Jalz.2018.06.835 |
0.771 |
|
| 2006 |
Vidoni ED, Clutton J, Becker AM, Sherry E, Bothwell R, Mahnken JD, Wilkins HM, Lee P, Choi I, Brooks W, Reed G, Burns JM, Swerdlow RH. P4-009: TRIAL OF OXALOACETATE IN ALZHEIMER'S DISEASE (TOAD): INTERIM FDG PET ANALYSIS Alzheimer's & Dementia. 14: P1435-P1436. DOI: 10.1016/J.Jalz.2018.06.2411 |
0.615 |
|
| 2006 |
Wilkins HM, Weidling I, Swerdlow RH. P1-227: MITOCHONDRIAL MEMBRANE POTENTIAL INFLUENCE ON PROCESSING AND LOCALIZATION OF APP Alzheimer's & Dementia. 14: P365-P365. DOI: 10.1016/J.Jalz.2018.06.232 |
0.807 |
|
| 2006 |
Michaelis EK, Pal R, Schoneich C, Wilkins HM, Swerdlow RH, Michaelis ML. P1-225: PROTECTION AGAINST AB-INDUCED NEURONAL DAMAGE BY AN HSP90 C-TERMINAL MODULATOR: IMPORTANCE OF PYRUVATE DEHYDROGENASE KINASE Alzheimer's & Dementia. 14: P364-P365. DOI: 10.1016/J.Jalz.2018.06.230 |
0.598 |
|
| 2006 |
Morris JK, John CS, Wilkins HM, Wang X, Weidling I, Thyfault JP, Vidoni ED, Swerdlow RH, Burns JM. P3-231: ALZHEIMER'S DISEASE SUBJECTS EXHIBIT IMPAIRED SYSTEMIC GLUCOSE METABOLISM FOLLOWING A MIXED MEAL Alzheimer's & Dementia. 14: P1159-P1160. DOI: 10.1016/J.Jalz.2018.06.1590 |
0.794 |
|
| 2006 |
Weidling I, Wilkins HM, Koppel SJ, Wang X, Gamblin TC, Swerdlow RH. P3-186: RESPIRATORY CHAIN INCOMPETENCE ALTERS TAU HOMEOSTASIS Alzheimer's & Dementia. 14: P1138-P1138. DOI: 10.1016/J.Jalz.2018.06.1544 |
0.79 |
|
| 2006 |
Swerdlow RH, Hui D, Wang X, Mahnken JD, Michaelis EK. P3-101: MTDNA HAPLOGROUP ASSOCIATIONS WITH ALZHEIMER'S DISEASE RISK Alzheimer's & Dementia. 14: P1106-P1106. DOI: 10.1016/J.Jalz.2018.06.1458 |
0.383 |
|
| 2005 |
Binder DR, Dunn WH, Swerdlow RH. Molecular characterization of mtDNA depleted and repleted NT2 cell lines. Mitochondrion. 5: 255-65. PMID 16050988 DOI: 10.1016/J.Mito.2005.04.003 |
0.372 |
|
| 2004 |
Barrett MJ, Alones V, Wang KX, Phan L, Swerdlow RH. Mitochondria-derived oxidative stress induces a heat shock protein response. Journal of Neuroscience Research. 78: 420-9. PMID 15389841 DOI: 10.1002/Jnr.20249 |
0.312 |
|
| 2004 |
Swerdlow RH, Khan SM. A "mitochondrial cascade hypothesis" for sporadic Alzheimer's disease. Medical Hypotheses. 63: 8-20. PMID 15193340 DOI: 10.1016/J.Mehy.2003.12.045 |
0.524 |
|
| 2004 |
Cardoso SM, Santana I, Swerdlow RH, Oliveira CR. Mitochondria dysfunction of Alzheimer's disease cybrids enhances Abeta toxicity. Journal of Neurochemistry. 89: 1417-26. PMID 15189344 DOI: 10.1111/J.1471-4159.2004.02438.X |
0.513 |
|
| 2004 |
Trimmer PA, Keeney PM, Borland MK, Simon FA, Almeida J, Swerdlow RH, Parks JP, Parker WD, Bennett JP. Mitochondrial abnormalities in cybrid cell models of sporadic Alzheimer's disease worsen with passage in culture. Neurobiology of Disease. 15: 29-39. PMID 14751768 DOI: 10.1016/J.Nbd.2003.09.011 |
0.475 |
|
| 2002 |
Swerdlow RH, Kish SJ. Mitochondria in Alzheimer's disease. International Review of Neurobiology. 53: 341-85. PMID 12512346 DOI: 10.1016/S0074-7742(02)53013-0 |
0.509 |
|
| 2002 |
Morais Cardoso S, Swerdlow RH, Oliveira CR. Induction of cytochrome c-mediated apoptosis by amyloid beta 25-35 requires functional mitochondria. Brain Research. 931: 117-25. PMID 11897097 DOI: 10.1016/S0006-8993(02)02256-4 |
0.43 |
|
| 2002 |
Swerdlow RH. Mitochondrial DNA--related mitochondrial dysfunction in neurodegenerative diseases. Archives of Pathology & Laboratory Medicine. 126: 271-80. PMID 11860299 DOI: 10.1043/0003-9985(2002)126<0271:Mdrmdi>2.0.Co;2 |
0.464 |
|
| 2001 |
Cardoso SM, Santos S, Swerdlow RH, Oliveira CR. Functional mitochondria are required for amyloid beta-mediated neurotoxicity. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 15: 1439-41. PMID 11387250 DOI: 10.1096/Fj.00-0561Fje |
0.429 |
|
| 2001 |
Swerdlow RH, Parks JK, Cassarino DS, Binder DR, Bennett JP, Di Iorio G, Golbe LI, Parker WD. Biochemical analysis of cybrids expressing mitochondrial DNA from Contursi kindred Parkinson's subjects. Experimental Neurology. 169: 479-85. PMID 11358461 DOI: 10.1006/Exnr.2001.7674 |
0.323 |
|
| 2001 |
Albers DS, Swerdlow RH, Manfredi G, Gajewski C, Yang L, Parker WD, Beal MF. Further evidence for mitochondrial dysfunction in progressive supranuclear palsy. Experimental Neurology. 168: 196-8. PMID 11170735 DOI: 10.1006/Exnr.2000.7607 |
0.456 |
|
| 2000 |
Swerdlow RH, Parks JK, Pattee G, Parker WD. Role of mitochondria in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group On Motor Neuron Diseases. 1: 185-90. PMID 11464951 DOI: 10.1080/14660820050515179 |
0.392 |
|
| 2000 |
Swerdlow RH, Golbe LI, Parks JK, Cassarino DS, Binder DR, Grawey AE, Litvan I, Bennett JP, Wooten GF, Parker WD. Mitochondrial dysfunction in cybrid lines expressing mitochondrial genes from patients with progressive supranuclear palsy. Journal of Neurochemistry. 75: 1681-4. PMID 10987850 DOI: 10.1046/J.1471-4159.2000.0751681.X |
0.647 |
|
| 2000 |
Veech GA, Dennis J, Keeney PM, Fall CP, Swerdlow RH, Parker WD, Bennett JP. Disrupted mitochondrial electron transport function increases expression of anti-apoptotic bcl-2 and bcl-X(L) proteins in SH-SY5Y neuroblastoma and in Parkinson disease cybrid cells through oxidative stress. Journal of Neuroscience Research. 61: 693-700. PMID 10972966 DOI: 10.1002/1097-4547(20000915)61:6<693::Aid-Jnr13>3.0.Co;2-4 |
0.366 |
|
| 2000 |
Cassarino DS, Halvorsen EM, Swerdlow RH, Abramova NN, Parker WD, Sturgill TW, Bennett JP. Interaction among mitochondria, mitogen-activated protein kinases, and nuclear factor-kappaB in cellular models of Parkinson's disease. Journal of Neurochemistry. 74: 1384-92. PMID 10737593 DOI: 10.1046/J.1471-4159.2000.0741384.X |
0.38 |
|
| 2000 |
Trimmer PA, Swerdlow RH, Parks JK, Keeney P, Bennett JP, Miller SW, Davis RE, Parker WD. Abnormal mitochondrial morphology in sporadic Parkinson's and Alzheimer's disease cybrid cell lines. Experimental Neurology. 162: 37-50. PMID 10716887 DOI: 10.1006/Exnr.2000.7333 |
0.483 |
|
| 2000 |
Khan SM, Cassarino DS, Abramova NN, Keeney PM, Borland MK, Trimmer PA, Krebs CT, Bennett JC, Parks JK, Swerdlow RH, Parker WD, Bennett JP. Alzheimer's disease cybrids replicate ?-amyloid abnormalities through cell death pathways Annals of Neurology. 48: 148-155. DOI: 10.1002/1531-8249(200008)48:2<148::Aid-Ana3>3.0.Co;2-7 |
0.459 |
|
| 1999 |
Ghosh SS, Swerdlow RH, Miller SW, Sheeman B, Parker WD, Davis RE. Use of cytoplasmic hybrid cell lines for elucidating the role of mitochondrial dysfunction in Alzheimer's disease and Parkinson's disease. Annals of the New York Academy of Sciences. 893: 176-91. PMID 10672237 DOI: 10.1111/J.1749-6632.1999.Tb07825.X |
0.469 |
|
| 1999 |
Caldwell SH, Swerdlow RH, Khan EM, Iezzoni JC, Hespenheide EE, Parks JK, Parker WD. Mitochondrial abnormalities in non-alcoholic steatohepatitis Journal of Hepatology. 31: 430-434. PMID 10488700 DOI: 10.1016/S0168-8278(99)80033-6 |
0.351 |
|
| 1999 |
Swerdlow RH, Parks JK, Cassarino DS, Shilling AT, Bennett JP, Harrison MB, Parker WD. Characterization of cybrid cell lines containing mtDNA from Huntington's disease patients. Biochemical and Biophysical Research Communications. 261: 701-4. PMID 10441489 DOI: 10.1006/Bbrc.1999.1095 |
0.423 |
|
| 1999 |
Swerdlow RH, Parker WD. Mitochondrial pathology in Parkinson's disease and implications for therapeutic intervention Drug Development Research. 46: 44-50. DOI: 10.1002/(Sici)1098-2299(199901)46:1<44::Aid-Ddr7>3.0.Co;2-6 |
0.431 |
|
| 1998 |
Swerdlow RH, Parks JK, Davis JN, Cassarino DS, Trimmer PA, Currie LJ, Dougherty J, Bridges WS, Bennett JP, Wooten GF, Parker WD. Matrilineal inheritance of complex I dysfunction in a multigenerational Parkinson's disease family. Annals of Neurology. 44: 873-81. PMID 9851431 DOI: 10.1002/Ana.410440605 |
0.353 |
|
| 1998 |
Swerdlow RH, Parks JK, Cassarino DS, Trimmer PA, Miller SW, Maguire DJ, Sheehan JP, Maguire RS, Pattee G, Juel VC, Phillips LH, Tuttle JB, Bennett JP, Davis RE, Parker WD. Mitochondria in sporadic amyotrophic lateral sclerosis. Experimental Neurology. 153: 135-42. PMID 9743575 DOI: 10.1006/Exnr.1998.6866 |
0.383 |
|
| 1998 |
Cassarino DS, Swerdlow RH, Parks JK, Parker WD, Bennett JP. Cyclosporin A increases resting mitochondrial membrane potential in SY5Y cells and reverses the depressed mitochondrial membrane potential of Alzheimer's disease cybrids. Biochemical and Biophysical Research Communications. 248: 168-73. PMID 9675105 DOI: 10.1006/Bbrc.1998.8866 |
0.471 |
|
| 1998 |
Parker WD, Swerdlow RH. Mitochondrial dysfunction in idiopathic Parkinson disease. American Journal of Human Genetics. 62: 758-62. PMID 9529370 DOI: 10.1086/301812 |
0.396 |
|
| 1998 |
Swerdlow RH. Mitochondria and Free Radicals in Neurodegenerative Diseases The American Journal of Human Genetics. 63: 1567. DOI: 10.1086/302091 |
0.378 |
|
| 1997 |
Cassarino DS, Fall CP, Swerdlow RH, Smith TS, Halvorsen EM, Miller SW, Parks JP, Parker WD, Bennett JP. Elevated reactive oxygen species and antioxidant enzyme activities in animal and cellular models of Parkinson's disease. Biochimica Et Biophysica Acta. 1362: 77-86. PMID 9434102 DOI: 10.1016/S0925-4439(97)00070-7 |
0.349 |
|
| 1997 |
Swerdlow RH, Parks JK, Cassarino DS, Maguire DJ, Maguire RS, Bennett JP, Davis RE, Parker WD. Cybrids in Alzheimer's disease: a cellular model of the disease? Neurology. 49: 918-25. PMID 9339668 DOI: 10.1212/Wnl.49.4.918 |
0.657 |
|
| 1997 |
Sheehan JP, Swerdlow RH, Parker WD, Miller SW, Davis RE, Tuttle JB. Altered calcium homeostasis in cells transformed by mitochondria from individuals with Parkinson's disease. Journal of Neurochemistry. 68: 1221-33. PMID 9048769 DOI: 10.1046/J.1471-4159.1997.68031221.X |
0.344 |
|
| 1994 |
Smith TS, Swerdlow RH, Parker WD, Bennett JP. Reduction of MPP(+)-induced hydroxyl radical formation and nigrostriatal MPTP toxicity by inhibiting nitric oxide synthase. Neuroreport. 5: 2598-600. PMID 7535121 DOI: 10.1097/00001756-199412000-00048 |
0.55 |
|
| Show low-probability matches. |